What Does Elevated Zonulin Actually Mean?

If you’ve recently received lab results showing elevated zonulin, you’re probably wondering what this means for your health. Here’s the short answer: elevated zonulin is often one of the earliest red flags for increased intestinal permeability—what many people call “leaky gut”—and the systemic inflammation that follows.

The human intestine is a critical biological interface that regulates the interaction between the body’s internal environment and external factors. It plays a central role in maintaining gut permeability, immune responses, and overall health.

Zonulin is a protein that acts like a gatekeeper for your intestinal lining. It opens and closes the tight junctions between intestinal epithelial cells, controlling what gets through the gut barrier and what stays out. When we talk about “elevated zonulin,” we’re referring to higher-than-normal levels found on stool (fecal zonulin) or blood (serum zonulin) testing.

When zonulin levels rise and stay elevated, those tight junctions open too frequently or for too long. The result? Undigested food particles, bacterial toxins, and other contents from the digestive tract slip through the intestinal barrier and enter the blood stream. This triggers an immune response that can ripple throughout the body.

Zonulin is recognized as the only physiological protein that can reversibly regulate intestinal permeability by disassembling tight junctions. In fact, zonulin is the only known physiological modulator of intestinal permeability (*).

Leaky Gut Symptoms That You Might Not Realize

Patients with elevated zonulin levels often report a constellation of symptoms:

• Bloating, gas, and abdominal discomfort
• Diarrhea, constipation, or alternating patterns
• Brain fog and difficulty concentrating
• Persistent fatigue
• Joint pain and stiffness
• Skin rashes or eczema
• Autoimmune flares

Example of a patient: a 43-year-old woman presenting with irritable bowel syndrome IBS-D and Hashimoto’s thyroiditis. Her GI-MAP stool panel revealed elevated fecal zonulin alongside elevated calprotectin. This pattern tells me there’s both barrier dysfunction and active intestinal inflammation—information that shapes our entire treatment approach.

One thing I want to emphasize is that while elevated zonulin is not a diagnosis by itself, It’s a functional marker that helps guide a more comprehensive evaluation and personalized treatment plan. Think of it as one piece of a larger puzzle.

What Is Zonulin? (And How It Affects Your Gut Barrier)

Let’s start with the basics before diving deeper. Zonulin is a protein your body produces to regulate the spaces between cells in your intestinal lining. When functioning properly, it’s part of an elegant system that allows nutrients in while keeping harmful substances out.

On a more technical level, zonulin belongs to a family of proteins—including pre-haptoglobin-2 (pre-Hp2)—that regulate paracellular permeability. A Leaky gut comes in two flavors if you will. Paracellular which means through the cells, and Trancellular meaning betweening two adajacent cells.

The key players in this system are the intercellular tight junctions: protein complexes including claudins, occludin, and ZO-1 that act like the “zipper” or “gatekeeper” of your gut wall. These intercellular tight junctions are found in the intestinal epithelium, a dynamic barrier that regulates molecular trafficking and immune responses.

Zonulin is released by your own gut cells to regulate gut permeability and immune responses.

Interestingly, zonulin is produced not only in the small intestine, but also in the liver, skin, brain, lungs, kidneys, and immune cells. This multi-organ production is important for understanding why serum zonulin levels can reflect more than just gut function.

Ever hear of a leaky brain? or Leaky Lungs? How about Leaky skin? The same leaky gut phenomenon can affect other tissues in the body.

What Causes Elevated Zonulin? (Gluten, Infections, Stress, Medication and More)

Zonulin release isn’t random. It’s triggered by specific factors in genetically and environmentally susceptible individuals. Understanding these triggers causing and elevation in your zonulin levels can be essential for developing an effective treatment strategy when suffering with a chronic health problem.

Major categories leading to an Incease in zonulin levels:

• Gluten and gliadin peptides (particularly in wheat, barley, and rye)
• Bacterial overgrowth and gut dysbiosis
• Bacterial infections (such as those caused by pathogenic bacteria producing LPS and peptidoglycans)
• Gut infections (protozoa, parasites, pathogenic bacteria)
• Systemic inflammation and metabolic syndrome
• Chronic psychological/Emotional stress
• Alcohol consumption
• Certain medications (especially NSAIDs)

Bacterial infections can disrupt intestinal barrier function, leading to increased zonulin release. This disruption contributes to inflammation and has been linked to metabolic disorders such as insulin resistance. Not everyone responds to these triggers the same way.

Your genetics (including the HP2 phenotype and HLA-DQ2/DQ8 variants), diet, microbiome composition, and overall immune status all influence how much zonulin is released and whether it becomes problematic.

In clinical practice, we often see elevated stool zonulin either on Cyrex array 2 or  GI-MAP panels in patients with a combination of dysbiosis, protozoal infection, and high processed-gluten intake. Rarely is it just one factor.

One important clarification: while gluten is a well-studied trigger for leaky gut, its not the only cause. There can be many reasson or root causes of a leaky gut.

Many patients with elevated zonulin do not have celiac disease but do test positie to Gluten or Gliadin. The conversation about gluten should be individualized and testing-based rather than generalized.

Read: What Are Lipopolysaccharides

Gluten, Gliadin, and Other Food Triggers

Alpha-gliadin—a component of gluten found in wheat, barley, and rye—is one of the most thoroughly researched triggers for zonulin release. The mechanism has been mapped in considerable detail.

Here’s how it works:

1. Gliadin peptides bind to the CXCR3 receptor on intestinal cells (particularly in the jejunum and distal ileum)
2. This activates a MyD88-dependent pathway
3. The pathway triggers zonulin release from intestinal cells
4. Zonulin then causes disassembly of tight junction proteins (ZO-1, occludin)
5. The result is increased paracellular permeability
6. Antigens can now reach immune cells in the lamina propria, potentially triggering inflammation

This mechanism is especially pronounced in people with celiac disease genetics (HLA-DQ2/DQ8) or the HP2 phenotype. However, non-celiac gluten sensitivity (NCGS) can also manifest with elevated zonulin levels, even when celiac serologies are negative [1][7].

Research has shown that serum zonulin levels in celiac and NCGS patients are significantly elevated compared to healthy controls, with some studies suggesting specificity around 88% at certain thresholds. However, this remains an area of ongoing investigation.

Other potential food triggers include:

• Dairy proteins (casein, whey)
• Food additives and emulsifiers
• Alcohol
• Highly processed foods
• Bacterial cell fragments and bacterial toxins
• Medications 

The practical takeaway? When elevated zonulin is present, a structured elimination trial—not a fear-based permanent restriction—is often the appropriate starting point. Testing and careful reintroduction help us determine what actually matters for each patient.

Read: Medications That Cause Leaky Gut and SIBO

Bacterial Overgrowth, Dysbiosis, and Infections

Your gut bacteria can directly and indirectly induce zonulin expression, especially when there’s overgrowth, loss of microbial diversity, or outright infection. This is one of the most common patterns we see in clinical practice.

Small intestinal bacterial overgrowth (SIBO) and colonic dysbiosis frequently accompany elevated fecal zonulin. Patients typically present with gas, bloating, altered bowel habits, and often irritable bowel syndrome symptoms.

The research shows that bacterial products—particularly lipopolysaccharide (LPS) from Gram-negative bacteria—correlate with higher serum zonulin levels and systemic inflammation. This connection is especially strong in metabolic syndrome and type 2 diabetes [1][8].

Parasitic infections deserve special attention. Organisms like Blastocystis hominis and Giardia can drive intestinal inflammation, elevate calprotectin, elevated histamine levels and cause secondary zonulin elevation.

Pathogenic bacteria produce bacterial toxins (LPS toxins) that can directly trigger an increase in zonulin secretion. These factors then lead to an increase in leaky gut, which is a root cause of chronic inflammatory diseases such as celiac disease and autoimmune conditions (*),(*).

Systemic Inflammation, Metabolic Syndrome, and Lifestyle Factors

Chronic low-grade inflammation from obesity, insulin resistance, and non-alcoholic fatty liver disease (NAFLD) is consistently associated with higher serum zonulin levels compared to healthy controls (*).

Remember that adipose tissue, liver, and other organs can secrete zonulin-family proteins. This makes serum zonulin a useful marker for metabolic dysregulation, but less specific to the gut wall alone.

The evidence linking elevated zonulin to metabolic conditions is substantial:

Beyond metabolic factors, lifestyle significantly affects gut function (*):

• Chronic psychological stress disrupts barrier function through the gut-brain axis
• Sleep deprivation impairs mucosal repair and immune regulation
• Alcohol use directly damages the intestinal mucosa
• High NSAID use compromises intestinal barrier integrity

The practical angle: addressing diet, blood sugar balance, body composition, and stress management often improves both symptoms and follow-up zonulin levels.

We frequently see zonulin trend down over 6–12 months when patients shift to an anti-inflammatory diet, reduce alcohol, normalize sleep, improve insulin sensitivity and follow a supplement regiment aimed at healing the gut barrier.

Read: Leaky Gut Not Healing? 7 Tips To Heal Your Leaky Gut

Health Conditions Linked to Elevated Zonulin and Leaky Gut

Elevated zonulin has been associated with a wide range of conditions—gastrointestinal, autoimmune, metabolic, neuroinflammatory, and even oncologic. The strength of evidence varies considerably across these conditions.

Increased intestinal permeability due to zonulin-mediated loosening of tight junctions can lead to increased water loss and dehydration in gut putting sufferers, highlighting the clinical impact of this mechanism.

Here’s an important perspective we emphasize at DrHagmeyer.com: association does not always equal causation. We use zonulin as part of a functional map, not as a stand-alone explanation for complex disease.

The following subsections summarize key conditions where zonulin and intestinal permeability have been studied. For clinicians and informed readers wanting to dive deeper, key reviews include Fasano’s work on the zonulin pathway and chronic inflammatory diseases, as well as more recent analyses in Frontiers in Immunology and F1000Research [1][2][5].

Celiac Disease and Non-Celiac Gluten Sensitivity and Zonulin

Celiac disease—affecting roughly 1 in 100–150 people in North America and Europe—is the classic model for understanding zonulin’s role in disease. When someone with coeliac disease consumes gluten, gliadin induces zonulin release, leading to villous atrophy, malabsorption, and autoimmune inflammation.

The sequence is well-documented:

1. Gliadin-induced zonulin release increases intestinal permeability zonulin-mediated
2. Gluten peptides cross the barrier and interact with immune cells
3. This drives tissue transglutaminase autoimmunity
4. Chronic inflammation and villous damage follow

Serum zonulin levels and fecal zonulin are often elevated in active celiac disease and tend to decrease—though sometimes incompletely—on a strict gluten free diet.

Non-celiac gluten sensitivity (NCGS) presents a different picture. These patients have gluten-triggered symptoms and elevated zonulin with increased permeability, but negative celiac serologies and biopsies. Studies have confirmed that zonulin release occurs in NCGS, suggesting a shared mechanism even without the full celiac phenotype [1][7].

Clinical nuance matters here: not every patient with digestive complaints and elevated zonulin has celiac disease. Formal celiac testing (tTG IgA, EMA, total IgA, and HLA typing when indicated) should precede definitive conclusions.

IBS, IBD, and Other Intestinal Disorders and Zonulin

Increased intestinal permeability has been documented in irritable bowel syndrome (especially IBS-D) and inflammatory bowel disease (Crohn’s disease and ulcerative colitis), though zonulin data are more variable.

What we see clinically:

• Fecal zonulin can be elevated in IBS-D, microscopic colitis, and active inflammatory bowel disease
• Elevation often correlates with diarrhea frequency and inflammatory markers like calprotectin
• Elevated zonulin plus high fecal calprotectin or lactoferrin raises suspicion for IBD and may prompt referral for colonoscopy and imaging

However, some patients with IBS have normal zonulin. Conversely, some asymptomatic individuals may have mildly elevated levels of zonulin. Context and symptom correlation are essential.

The conditions where zonulin mediated gut permeability appears relevant include:

• IBS-D (diarrhea-predominant)
• IBS-M (mixed pattern)
• Crohn’s disease
• Ulcerative colitis
• Microscopic colitis
• Post-infectious IBS

Barrier-directed therapies—specific probiotics, flavonoids, elimination diets—can complement conventional GI care. They don’t replace it.

Autoimmune, Metabolic, and Neuroinflammatory Conditions and Zonulin

The research linking elevated zonulin and increased gut permeability with autoimmune diseases is compelling, if not yet definitive for all conditions.

Autoimmune connections include:

• Type 1 diabetes (T1D): 42% of 339 patients showed abnormal serum zonulin versus controls. Strikingly, 70% of pre-T1D subjects had elevated zonulin 3.5 ± 0.9 years before disease onset [2].
• Rheumatoid arthritis (RA): Zonulin expression correlates with disease onset, accompanied by dysbiosis and ZO-1 disengagement [5].
• Multiple sclerosis: Emerging data suggests zonulin-dependent barrier dysfunction may contribute to neuroinflammation.
• Ankylosing spondylitis: Association with increased gut permeability and HLA-B27.

In some cohorts, increased intestinal permeability and serum zonulin have been detected before overt autoimmune disease onset—in first-degree relatives or autoantibody-positive individuals—suggesting a possible “early warning” role.

Metabolic connections:

The connection between obesity, metabolic syndrome, non-alcoholic fatty liver disease, and elevated serum zonulin is likely mediated by LPS-induced inflammation and adipose/liver secretion of zonulin family proteins. Insulin resistance and transforming growth factor beta dysregulation may also play roles.

Neuroinflammatory and psychiatric conditions:

When the gut barrier is compromised, bacterial fragments—especially lipopolysaccharide (LPS) from certain Gram-negative bacteria—can more easily move from the gut into circulation (“metabolic endotoxemia”).

That tends to trigger inflammatory signaling (TNF-α, IL-6, etc.), which can weaken tight junction proteins in the Blood Brain Barrier (BBB) and increase BBB permeability.

Inflammatory signals coming from the periphery can activate microglia. Microglia are the brain and spinal cord’s resident immune cells—think of them as the CNS’s on-site security and cleanup crew. But heres a major problem when it come to overactive microglia.

Once activated, microglia can amplify neuroinflammation, which is one reason researchers connect gut-driven inflammation with symptoms like brain fog, mood changes, and fatigue in some people.

Emerging research associates high zonulin and “leaky gut–leaky brain” patterns with:

• Autism spectrum disorders
• Schizophrenia
• Major depressive disorder
• Neurodegeneration
• Traumatic Brain Injury

Cancer and Aging

Evidence suggests that zonulin and related permeability pathways may play a role in certain cancers. Elevated zonulin expression has been observed in gliomas, and higher serum levels have been found in hepatocellular carcinoma and advanced liver disease.

The proposed mechanism: chronic intestinal barrier dysfunction and endotoxemia create a pro-carcinogenic environment in the liver and possibly other organs through sustained inflammation and immune dysregulation.

Research on aging is equally intriguing. Data linking elevated zonulin, low-grade endotoxemia, and frailty in older adults suggests that better-preserved intestinal mucosal barrier function is associated with healthier aging and potentially longevity.

To be clear: in clinical practice, zonulin is not used as a cancer screening tool. However, its presence reinforces the need to address gut barrier, inflammation, detoxification, and microbiome health as part of an integrative approach to affect gut function long-term.

How Do We Test Zonulin and Gut Permeability? (And Why Retesting Matters)

At DrHagmeyer.com, testing and retesting are central to my approach. We don’t guess, we test—and then we track progress over time to ensure our interventions are actually working.

Primary testing options for evaluating zonulin and intestinal barrier function include:

Test Type	What It Measures	Best Used For
Fecal zonulin (GI-MAP, other stool panels)	Local gut barrier secretion	Assessing intestinal permeability specifically
Serum zonulin + zonulin-family peptides	Systemic levels (gut + other organs)	Metabolic and autoimmune correlation
Antibody panels to tight junction proteins	Immune response to barrier proteins	Chronic barrier injury assessment
LPS, LBP, I-FABP	Endotoxemia + enterocyte damage	Systemic inflammation from gut origin

Why Retesting Zonulin Matters:

Repeating zonulin tests after 6–9 months of treatment documents improvement, and guides protocol adjustments. In my practice, Gut healing is measurable, and patients deserve to see their progress and know that what we do goes beyond temporary improvements in symptoms.

A clear clinical workflow looks in my Functional Medicine Practice Might look something like this:

1. Initial assessment and symptom evaluation (Case review)
2. Baseline blood test panel
3. Baseline GI marker panel. This might include tests like (GI-MAP with zonulin, or a Cyrex Array 2 panel, Calprotectin, sIgA, serum markers)
4. Individualized treatment plan
5. Retest at appropriate interval
6. Refine plan based on results

Current assays have technical limitations and cross-reactivity issues, so results should be interpreted by clinicians familiar with functional and conventional GI testing—not as DIY diagnoses.

Read More about GI MAP with Zonulin Testing Here

Read More about Cyrex Array 2 Panel Testing Here

How We Treat Elevated Zonulin and Leaky Gut (Dr. Hagmeyer’s Functional Approach)

Our therapeutic strategy follows a structured framework: remove triggers, calm inflammation, repair the barrier, rebalance the microbiome, and then re-challenge while monitoring labs.

This approach can be summarized as:

1. Remove — Eliminate triggers (problematic foods, infections, toxins)
2. Replace — Restore digestive function (enzymes, acids as needed)
3. Reinoculate — Introduce beneficial bacteria and prebiotics
4. Repair — Support intestinal mucosal barrier function with targeted nutrients
5. Rebalance — Address lifestyle factors (stress, sleep, movement)

Treatment is personalized based on test results, health history, and coexisting conditions. There’s no one-size-fits-all “zonulin supplement.”

Critical point: treatment runs in parallel with any conventional care—gastroenterology, endocrinology, rheumatology. Patients should not stop prescribed medications without coordination with their healthcare team.

Monitoring progress through symptom tracking and follow-up testing (zonulin and related markers) confirms that small intestine barrier function is actually improving.

Read: 10 Most Common Causes Of A Leaky Gut

Dietary Strategies and Gluten Management

Because gluten and gliadin are strongly linked to zonulin release, most patients with elevated zonulin benefit from a structured trial of gluten removal—at least temporarily.

Our typical approach:

• 8–12 week gluten-free trial (longer in confirmed celiac disease)
• Careful symptom tracking throughout
• Follow-up testing when appropriate
• Structured reintroduction if tolerated

An anti-inflammatory, gut-healing diet emphasizes:

• Whole, unprocessed foods
• Non-starchy vegetables and low-sugar fruits
• High-quality proteins (grass-fed, wild-caught when possible)
• Healthy fats (olive oil, avocado, omega-3 rich sources)
• Removal of common irritants (gluten, industrial seed oils, excess alcohol, ultra-processed foods)

In select patients with IBS or inflammatory bowel conditions, targeted elimination diets like low-FODMAP, Low Histamine, or AIP may be indicated based on testing and clinical presentation.

Any restrictive diet should be supervised by a knowledgeable practitioner or nutritionist. We want to avoid nutrient deficiencies and disordered eating patterns while pursuing gut health goals.

Read: Foods That Cause Chronic Inflammation? Stop Eating These Inflammatory Foods Today!

Targeted Nutraceuticals: Flavonoids, Probiotics, and Barrier Support

Several categories of supplements support tight junction structure and reduce zonulin-driven permeability.

• Immunoglobulins
• Glutamine
• DGL
• NAG
• Zinc
• Vitamin A
• Gamma Oryzanol
• Propolis
• Complete Turmeric Matrix
• Skull Cap Root Extract

These compounds have anti-inflammatory and antioxidant properties shown to help stabilize epithelial tight junctions and mucous membranes. They help regulate tight junction structure at the cellular level.

Probiotic strains with barrier support evidence:

 

• Lactobacillus rhamnosus GG (strongest evidence)
• Bifidobacterium longum
• Saccharomyces boulardii
• Multi-strain combinations based on individual needs

Research supports that specific probiotic strains improve barrier function and reduce intestinal permeability in IBS and other conditions.

Read: Best Probiotics For Leaky Gut- Why Some Work and Why Some Don’t

Gut repair nutrients:

• L-glutamine (primary fuel for gut cells)
• Zinc carnosine
• N-acetyl glucosamine
• Omega-3 fatty acids
• Soothing botanicals: deglycyrrhizinated licorice, aloe vera, slippery elm

Dosing, strain selection, and combinations should be guided by stool test findings and individual tolerance. Some patients with SIBO or histamine issues may initially react poorly to certain probiotics—this requires careful management.

Medical supervision is essential, especially in pregnant women, children, patients on immunosuppressants, or those with a history of severe GI disease.

Read: Supplements to Heal A Leak Gut A Multipronged Approach

Addressing Infections, Dysbiosis, and Systemic Drivers

Treating underlying infections—protozoa, parasites, overgrowth of pathogenic bacteria or yeast—is often the first step to lowering zonulin and restoring intestinal barrier integrity.

Treatment options may include:

• Targeted herbal protocols (berberine, oregano oil, etc.)
• Biofilm disruptors
• Motility support
• Tailored approaches based on GI-MAP or similar results

Systemic drivers must be addressed in parallel. Uncontrolled blood sugar, obesity, and chronic inflammatory conditions will keep zonulin elevated regardless of other interventions.

Collaborative care is sometimes essential. In some cases, I coordinate with GI specialists, endocrinologists, rheumatologists, and primary care to align functional and conventional plans.

The Importance of Retesting and Long-Term Maintenance

Gut healing is a process, not an event. Healing your gut is not something that happens overnight and sometime patients dont realize how involved healing the gut can be. Retesting zonulin and companion markers after 3–9 months is crucial to confirm objective improvement and fine tune or adjust the treatment plan.

Some patients normalize zonulin quickly. Others require longer-term support. Retesting prevents both over-treatment (continuing protocols that aren’t needed) and under-treatment (stopping too soon).

Long-term gut-protective lifestyle includes:

• Whole-food nutrition focused on variety and nutrient density
• Active stress reduction practices
• Adequate sleep (7–9 hours for most adults)
• Periodic probiotic and prebiotic support
• Limited alcohol and NSAID use
• Regular movement and exercise

For high-risk individuals—strong autoimmune family history, prior IBD, multiple autoantibodies—periodic monitoring of zonulin and barrier markers may be part of a preventative strategy.

A final reassuring message: healing the gut barrier is achievable and measurable. You don’t have to navigate this alone, and with the right testing and guidance, most patients see meaningful improvement in both their labs and how they feel.

Frequently Asked Questions About Elevated Zonulin

This FAQ addresses the most common questions we hear in clinic and via email about zonulin, leaky gut, and testing.

Q1: If my zonulin is elevated, does that mean I have leaky gut?

Elevated zonulin strongly suggests increased gut permeability, but confirmation comes from the full clinical picture—symptoms, additional markers (like calprotectin and LPS/LBP), and sometimes direct permeability testing via lactulose/mannitol. Zonulin is an important piece of evidence, not the whole story.

Q2: Do high zonulin levels mean I have celiac disease?

No. While zonulin is often elevated in celiac disease, it can also be elevated in many other conditions—IBS, autoimmune diseases, metabolic syndrome, and infections. Formal celiac testing (tTG IgA, EMA, total IgA, and sometimes HLA typing) is needed before making that specific diagnosis.

Q3: Can I lower my zonulin just by going gluten-free?

Gluten removal may help, especially if gliadin is a significant trigger for you. However, other factors—infections, dysbiosis, chronic stress, alcohol, metabolic issues—usually need to be addressed for sustained improvement. A gluten-free diet alone is rarely sufficient.

Q4: How long does it take for zonulin to normalize?

Realistic timelines vary widely. Most patients see improvement within 6–9 months of consistent intervention; some take longer depending on the underlying causes. Retesting is essential to measure progress rather than guessing.

Q5: Are zonulin tests reliable?

Current assays have acknowledged limitations and cross-reactivity concerns—some may detect related proteins rather than zonulin itself. However, when interpreted correctly and combined with other markers, zonulin testing remains clinically useful. The key is interpretation by someone experienced in functional GI testing.

Q6: Can I order zonulin testing on my own?

While some direct-to-consumer options exist, partnering with a clinician trained in functional and conventional GI testing leads to better interpretation and safer, more effective treatment. A number on a lab report means little without proper clinical context.

Q7: Is there a single supplement that “fixes” elevated zonulin?

No. There’s no one magic pill for intestinal barrier dysfunction. A comprehensive, personalized plan is required—targeting diet, microbiome, inflammation, specific supplementation and lifestyle factors. Anyone promising a single supplement solution or a 90 days Leaky gut Cure isn’t giving you the full picture.

Key References and Further Reading

This is a non-exhaustive list of peer-reviewed articles and reviews to support clinicians and informed readers who want to explore this topic more deeply.

• Fasano A. 2012. Clinical Reviews in Allergy & Immunology – “Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer.”
• Fasano A. 2011. Physiological Reviews – “Zonulin and its regulation of intestinal barrier function.”
• Sturgeon C, Fasano A. 2016. Tissue Barriers – “Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.”
• Ajamian M, et al. 2019. Gut – “Serum zonulin as a marker for intestinal permeability: technical limitations and clinical relevance.”
• Drago S, et al. 2006. Scandinavian Journal of Gastroenterology – “Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa.”
• Sapone A, et al. 2011. BMC Medicine – “Spectrum of gluten-related disorders: consensus on new nomenclature and classification.”
• Zak-Gołąb A, et al. 2013. Journal of Physiology and Pharmacology – “Serum zonulin concentration is associated with metabolic syndrome and obesity.”
• Moreno-Navarrete JM, et al. 2012. Journal of Clinical Endocrinology & Metabolism – “Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.”
• de Punder K, Pruimboom L. 2015. Frontiers in Immunology – “Stress, the gut microbiome, and the vagal pathway: the zonulin link.”
• Vojdani A, et al. 2017. Clinical Reviews in Allergy & Immunology – “Antibodies against LPS, bacterial toxins, and zonulin in autoimmune and chronic inflammatory conditions.”

For additional resources on gut barrier testing and functional approaches, visit our detailed guides on GI-MAP testing and gut repair protocols at DrHagmeyer.com.

---